CS Paper Radar

LUCQUE: A lung cancer screening dataset from Québec for reliable AI evaluation

Johanna Topalis, Yannick Lemaréchal, Gabriel Couture, Hanife Ersay, Loran Nas, Balthasar Schachtner, Bastian Oliver Sabel, Michael Ingrisch, Philippe Després, Katharina Jeblick

cs.DB cs.AI ·submitted 2026-11-09 18:21 UTC · v1

Abstract

BACKGROUND: AI-based tools are expected to play a key role in lung cancer screening (LCS). The evaluation of these tools often relied on private datasets or fragmented public datasets with inconsistent availability of clinical data and expert nodule annotations. This has hindered reproducibility, comparability, and independent assessment of AI tools. To address these gaps, we present LUCQUE, a novel, large, comprehensively annotated dataset derived from LDCT lung cancer screening in Québec, which is accessible for reliable AI evaluation. METHODS: LUCQUE was curated and is hosted on PARADIM, a digital infrastructure supporting DICOM data de-identification, annotation, long-term storage and analysis. LDCT scans and clinical information were combined to a curated collection and complemented by voxel-level, expert-derived pulmonary nodule and cyst segmentations, and Lung-RADS-based lesion characteristics. Key dataset characteristics and statistics were reported, including participant demographics, imaging parameters, radiological findings, and segmented lesion characteristics. Dataset analyses were conducted according to PARADIM's model-to-data approach, in which user code is executed on the platform such that data remains on premise. RESULTS: LUCQUE currently comprises 1,678 LDCT baseline studies from 1,678 participants. Most studies were classified as Lung-RADS 2. A total of 1,776 pulmonary nodules and 60 cysts were annotated, with a median (interquartile range) volume of $89\,(56,\,159)\,\mathrm{mm}^3$ and $1,384\,(589,\,3793)\,\mathrm{mm}^3$ respectively. CONCLUSIONS: Compared to publicly available LCS datasets, LUCQUE currently represents the largest accessible annotated real-world LCS dataset. Access to LUCQUE is provided via a model-to-data approach, enabling privacy-preserving, reproducible, and independent real-world evaluation of AI tools in LCS.

Closest papers

Nearest neighbours by meaning across the whole index.

Disentangling Lung-Cancer CT/LDCT AI: A Systematic Evidence Map of Clinical Tasks, Evidence Chains, and Translational Gaps

cs.LG ·2026-09-28 ·Surajit Das
similarity 0.77
Abstract

Artificial-intelligence studies using computed tomography (CT) for lung cancer are often broadly labelled "prediction" despite addressing clinically distinct tasks. We systematically mapped CT/low-dose CT (LDCT)-centered lung-cancer AI using five-database retrieval, full-text eligibility assessment, role-aware modality/omics extraction, clinical-task classification, and a Multi-Tier Evidence Graph (MTEG). The final corpus comprised 293 studies (2016-2026): 230 Detection, 8 future Risk-prediction, and 55 Other studies. Clinical variables (96.2%), 3D CT/LDCT (73.0%), and radiomics (63.5%) predominated, whereas external validation (29.0%), calibration (20.5%), decision-curve analysis (13.0%), longitudinal CT (17.7%), and saliency/attribution XAI (21.5%) were less frequent. The MTEG comprised 377 nodes and 3,444 edges; only 31 studies (10.6%) completed the six-tier substantive evidence chain, with greatest attrition at reasoning/explanation. Overall, the literature is detection-dominated, genuine future risk prediction remains uncommon, and complete translational evidence chains are rare.

0.08

Annotating anatomy and pathology in the National Lung Screening Trial computed tomography images

eess.IV ·2026-09-09 ·Deepa Krishnaswamy, Vamsi Thiriveedhi, Suraj Pai, David Clunie, Igor Octaviano +4 more
similarity 0.76
Abstract

Large-scale public medical imaging datasets contribute critically to translational research. When accompanied by rich clinical and multi-omics data, they can stimulate exploratory research and enable secondary analyses. Expert annotations of such imaging collections can support the development of new image analysis tools. Continuous enrichment of images with image-derived data makes them more usable for researchers without expertise in image analysis or access to large-scale computational resources. The National Lung Screening Trial (NLST) released a rich longitudinal dataset that includes Computed Tomography (CT) images for over 26,000 patients. We introduce three Digital Imaging and Communications in Medicine (DICOM) formatted datasets, complementing NLST CT images, shared as analysis results in the National Cancer Institute Imaging Data Commons (IDC). Two of those (IDC NLSTSeg and IDC NLSTSybil) contain DICOM-harmonized annotations and extracted measurements (for 581 and 601 NLST patients, respectively) shared earlier using research formats (Sybil and NLSTseg). The third one (TotalSegmentator-CT-Segmentations) contains volumetric segmentations generated using TotalSegmentator and radiomics features for each segment for 26,194 NLST patients.

0.18

LUCAID: Agentic Multimodal AI for Lung Cancer Precision Pathology

cs.CV cs.AIcs.LG ·2026-08-24 ·Marie-Lisa Eich, Kai Standvoss, Timo Milbich, Alexander Möllers, Miriam Hägele +28 more
similarity 0.75
Abstract

Lung cancer tissue diagnostics is complex, as therapy decisions in precision oncology rely on the integration of histomorphological, immunohistochemical, and molecular features. Yet pathological assessment remains largely visual and semi-quantitative and shows interobserver variability, while existing artificial intelligence (AI) tools cover only selected tasks, rarely reach generalizable expert-level performance, and lack prospective clinical validation. To address these challenges, we developed and clinically validated LUCAID, an agentic AI system for precision lung cancer pathology. An integrative agent couples diagnostic reasoning with nine modules that cover the full routine workflow, from quality control, tumor detection and segmentation, histological subtyping, tumor microenvironment profiling, tumor cellularity quantification, and predictive biomarker scoring (PD-L1, MET, TROP-2) to automated structured report generation. LUCAID enables users to interactively query the module outputs and generate reports that contextualize the results. Against large-scale expert ground-truth annotations, the analysis modules achieved F1 scores of 0.82-0.95. In prospective clinical validation, LUCAID reached 93.0% concordance with an expert-panel adjudicated reference standard across clinically actionable decisions, compared with 68.3-81.1% for five experienced thoracic pathologists.

0.26

Can Unsupervised Methods Outperform Supervised Deep Learning When Ground Truth Is Sparse? A Case Study of Bronchovascular Bundle Segmentation in Low-Dose CT

cs.CV ·2026-08-17 ·Anna Mrukwa, Marek Socha, Aleksandra Suwalska, Agata Durawa, Malgorzata Jelitto +7 more
similarity 0.74
Abstract · 17 pages, 4 figures. Part of this research was submitted to the international conference European Molecular Imaging Meeting 2026

Background Lung cancer remains the deadliest cancer worldwide because it is often diagnosed too late. Effective treatment depends on detection at an early screening stage. However, the growing number of patients and the limited number of radiologists lead to prolonged diagnostic waiting times. In very early stage lung cancer, nodule visibility is further reduced by adjacent blood vessels and airway walls, because nodules are often connected to or supplied by these structures. Task-specific analysis of the bronchovascular bundle is therefore important for efficient nodule detection, and its removal can increase the diagnostic potential of lung cancer screening. Materials and Methods To assess the efficacy of the proposed method, we used series from widely utilized LDCT datasets, including the Duke Lung Cancer Screening (DLCS) dataset and the Pilot Pomeranian Lung Cancer Screening Program. The proposed bronchovascular bundle segmentation pipeline, RONALD, operates on computed tomography images and returns binary masks of vessels and bronchi located in the lung parenchyma. The method includes a preprocessing stage with lung, lobe, and mediastinum segmentation, followed by separate vessel and bronchial tree segmentation. Results The proposed pipeline segmented the bronchovascular bundle in low-dose computed tomography scans while improving nodule retention compared with other segmentation methods: from 93.98% and 90.36% to 100% in DLCS, and from 83.16% and 62.36% to 99.92% in the Pomeranian dataset. Conclusion The resulting segmentations can improve lung nodule detection in the very early stages of lung cancer.

0.12

AMPLIFAI: A Multiphase CT Dataset for Benchmarking Clinical Reasoning in LI-RADS Assessment of Liver Lesions

cs.CV cs.LG ·2026-08-14 ·Pranav Kulkarni, Nikhil Shah, Amritansh Suryavanshi, Jana G. Delfino, James Tonascia +7 more
dataset similarity 0.66
Abstract · 15 pages, 6 figures, 3 tables

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide, with early detection improving survival from <20% to >70%. The standardized Liver Imaging Reporting and Data System (LI-RADS) criteria provide an imaging-based diagnostic framework to evaluate liver lesions for HCC, serving as a foundation for automating HCC detection with artificial intelligence (AI). However, the lack of large, publicly available datasets with high-quality annotations has limited the development and evaluation of AI models for automated LI-RADS assessment. We introduce AMPLIFAI dataset, the first public dataset of 590 multiphase abdominal CT studies annotated with LI-RADS categories, lesion size, and voxel-level segmentations for three major LI-RADS features: arterial phase hyperenhancement, washout, and enhancing capsule. The dataset was curated and harmonized from four public datasets and augmented with expert annotations from five board-certified radiologists and one resident. Following the Datasheets for Datasets format, this paper details the dataset's composition, curation and harmonization process, and annotation workflow to support transparent, reproducible research in medical imaging AI.

0.10

FZ-VLM: A Two Stage Florence-Zephyr Vision Language Model Framework for Pulmonary Nodule Characterization and Clinical Decision Making

cs.CV cs.AI ·2026-08-15 ·Pramit Dutta, Jenita Manokaran, Richa Mittal, Ryan Appleby, Eranga Ukwatta
similarity 0.65
Abstract

Lung cancer remains one of the leading causes of cancer-related mortality worldwide, and Computed Tomography (CT) is a primary imaging tool for screening and followup assessment. After pulmonary nodule detection, radiologists manually assess anatomical location, diameter, margin characteristics, and attenuation type to support risk assessment and clinical decision-making. However, this post-detection workflow is time-consuming and can be affected by inter-observer variability. Existing Artificial Intelligence methods often focus on isolated tasks, limiting their use as a unified, clinically grounded interpretation framework. This study presents FZ-VLM, a two-stage Florence-Zephyr Vision Language Model framework for unified structured pulmonary nodule characterization in lung CT. The framework uses a fine-tuned Florence-2 model to extract radiological attributes from expert-annotated 2D axial CT slices, while a Zephyr-7B model uses these attributes to generate nodule descriptions, follow-up recommendations, and longitudinal analyses. Results showed that the Stage 1 model achieved 77.18\% accuracy for anatomical location, 67.96\% accuracy for margin characteristics, and 79.13\% accuracy for attenuation type, with a Mean Absolute Error of 2.58 mm for diameter estimation, outperforming evaluated GPT-4-based baselines as well as the human baseline. Expert radiologist evaluation of Stage 2 showed 93.9\% accuracy, 98.6\% completeness score, 76.1\% clinical relevance, and an overall score of 89.5\%. Safety analysis showed that most outputs were clinically safe, although some follow-up recommendations still required expert review. To the best of our knowledge, this study presents the first two-stage Vision-Language Model framework for structured nodule characterization and clinical decision-making.

0.04

From Slices to Volumes: Comparing 2D, 2.5D, and 3D Residual Networks for Pulmonary Nodule Malignancy-Risk Classification

cs.LG cs.CV ·2026-10-25 ·Bahodir Nazarov, Zineb Gharib, Fatima Zazoul
code/data similarity 0.65
Abstract

Purpose: To compare 2D, 2.5D, and 3D residual networks for pulmonary nodule malignancy-risk classification and evaluate momentum-contrast pretraining, mild augmentation, and exclusion of indeterminate ratings. Methods: A retrospectively prepared LIDC-IDRI cohort contained 2,654 nodules labeled benign, indeterminate, or malignant using median radiologist ratings. Patient-disjoint splits comprised 1,876 training, 382 validation, and 396 test nodules. Representations included one axial slice, five neighboring slices, and a local CT volume. Each track evaluated a randomly initialized baseline, momentum-contrast pretraining followed by fine-tuning, and supervised training with mild augmentation. Checkpoints were selected by validation Macro-F1. The 2D experiments used three seeds; 2.5D and 3D results were single-run estimates. A separate binary experiment excluded indeterminate nodules. Results: Augmented models achieved test Macro-F1 values of $0.6134\pm0.0075$ for 2D, $0.6537$ for 2.5D, and $0.5403$ for 3D; the 2D uncertainty denotes population standard deviation across seeds. Corresponding accuracies were $0.6128$, $0.6869$, and $0.5455$. Augmentation improved Macro-F1 within every track, whereas the tested pretraining recipes reduced it. Binary Macro-F1 values were $0.8227$, $0.8664$, and $0.7554$, respectively. Conclusion: Augmented 2.5D achieved the highest observed performance. Differences in preprocessing, optimization, capacity, and replication limit attribution to dimensionality. Labels reflect radiologist-assessed malignancy risk rather than pathology-confirmed cancer. Code and experimental results are available at https://github.com/CT-DeepLearning-Team/CT-2D-2.5D-3D-DeepLearning.

0.18

FedHisto-PAST: Parameter-Efficient Stain-Aware Federated Learning for Cross-Site Lung Histopathology Classification

cs.CV cs.AI ·2026-09-25 ·Muhammad Muhtasim Shahriar, M. M. Golam Hafiz, Saad Aloteibi, Mohammad Ali Moni
similarity 0.64
Abstract · Submitted to Engineering Applications of Artificial Intelligence (Elsevier)

Cross-site lung histopathology classification must account for stain variation, non-IID client data, missing classes, and the cost of adapting large pathology encoders. This study evaluates FedHisto-PAST v2 for three-way classification of adenocarcinoma (ACA), Normal, and squamous cell carcinoma (SCC). FedHisto-PAST v2 combines a frozen HIBOU-B foundation model with parameter-efficient adaptation, stain-conditioned paired-view prediction and feature consistency, reliability-aware prototype learning, and adaptive federated aggregation. Experiments used a five-client, non-IID, raw-data-local simulation with fixed internal evaluation, client-level analysis, component ablations, communication accounting, and a development-influenced exploratory LungHist700 cohort. All principal methods achieved near- ceiling internal performance, which limited discrimination on the fixed split. On LungHist700, FedHisto- PAST v2 achieved a Macro-F1 of 0.728560 and a balanced accuracy of 0.730454. Higher recognition of Normal and SCC was accompanied by lower ACA recall, and calibration remained imperfect. Prediction-level consistency was the only component with a clearly supported independent contribution in the external ablation analysis. Feature consistency and prototype regularization showed no conclusive independent overall gains in Macro-F1. The framework updated 1.253841% of the model parameters. The results provide exploratory cross-dataset evidence for stain-aware, parameter-efficient federation; they do not establish formal privacy, patient-level independence, prospective deployment, or clinical validation.

0.26